Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2016 /
Polycomb repressors and epigenetic therapy

9th - 12th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.07.16
Views: 1748

Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK

Dr van Lohuizen speaks with ecancertv at EACR 2016 about polycomb repressors, determinants of cell fate, and their significance in genetic modification of cancer cells.

He describes how they exert a stabilising effect on tumourigenic stem cells, and disease states that arise through their aberrance. 

Dr van Lohuizen reports on results from lung cancer patients, and outlines his goals for deeper understanding of the genomic implications in future research.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation